GBIO
GBIO
NASDAQ · Biotechnology

Generation Bio Co

$5.34
-0.40 (-6.97%)
As of Mar 28, 1:46 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +226.6% upside
Low Target $9.95
Average Target $17.44
High Target $18.08
Current Price $5.34
Current
$5.34
Target
$17.44
$9.95 $17.44 avg $18.08
Scenario Analysis
Bear Case
$9.95
86.3%
Low target
Base Case
$17.44
+226.6%
Avg target
Bull Case
$18.08
+238.6%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$58.99
-90.9% from high
52-Week Low
$3.88
+37.6% from low
Target vs 52W High
$17.44
-70.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%